Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs ... in the interaction between MSCs and their target cells involves cell–cell contact mediated ...

The combination approach centers on mesenchymal stromal cells ... recognize specific disease-related markers. Chimeric antigen receptors have three crucial functions: 1) Target and attach to ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced ...

What if a single injection could slow aging and prevent cardiovascular disease? And what if that ... Blanc's work revolves around a group of cells called mesenchymal stem cells, or MSCs.

Then, they introduce the new stem cells, which are not primed to attack myelin. This appears to slow or stop disease progression ... a high level of disability. Mesenchymal stem cells are adult ...

randomized controlled trial was to determine the efficacy and safety of sequential umbilical cord–derived mesenchymal stem cell (UC-MSC) infusion for graft-versus-host disease (GVHD) prevention within ...

But the retractions of the Alzheimer’s paper on Monday and the stem cell paper ... found a molecular target that appeared influential in the onset of Alzheimer’s disease, which remains ...

More information: Jean Paul Chadarevian et al, Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins, Cell Stem Cell (2025). DOI: 10.1016/j.stem.2025.03.009 Provided ...

But the retractions of the Alzheimer's paper on June 24, and the stem cell paper on ... found a molecular target that appeared influential in the onset of Alzheimer's disease, which remains ...

Researchers used preclinical models to uncover Tim-3's role in microglia, the brain's resident immune cells, and have identified it as a promising therapeutic target for Alzheimer's disease.